AMGN Amgen

  • AMGN
  • Price as of: Jan 23, 11:26 AM EST
  • $152.87
  • -$1.80
  • -1.2%
  • Industry
  • Biotechnology

AMGN Stock Dividend Data

Add AMGN to Watchlist
  • Dividend Yield
    3.01% Healthcare Average 0.91%
  • Annualized Payout
    $4.60 Paid Quarterly
  • Payout Ratio
    39.9% EPS $11.53
  • Dividend Growth
    6 yrs Since 2011
  • Get AMGN DARS™ Rating

Looking to buy or sell AMGN?

Buy Now
Sell Now
Upcoming Dividend Payouts

AMGN Upcoming Dividend Payouts

Next Ex-Dividend Date
Feb 13
Dividend Shot Clock®
Feb 13, 2017
Feb 13, 2017
Date has passed
Next Ex-Dividend Date
Next Pay Date
Amount Declare Date Ex-Dividend Date ▲ Record Date Pay Date Payout Type
$1.1500 2016-12-20 2017-02-13 2017-02-15 2017-03-08 Regular
DARS Rating™ Breakdown DARS Rating™ Breakdown for AMGN

Sign Up
Metric AMGN Rank AMGN Avg Ranking Notes
Relative Strength 1 year return is slightly above Benchmark/Peers/Broader Market/Analyst Expectations
Overall Yield Attractiveness Yield is at par with Benchmark/Peers/Broader Market/Analyst Expectations
Dividend Reliability Payout ratio is considerably higher than industry average and peers
Dividend Uptrend Dividends are above average, growing as per Benchmark/Peers/Broader Market/Analyst Expectations
Earnings Growth EPS growth is at par with Benchmark/Peers/Broader Market/Analyst Expectations
DARS Rating Sign Up For DARS Ratings

Brought to You by Mitre Media

Growth History

AMGN Dividend Growth History

Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Years of
28.6% 26.6% 6 years
Reveal More Dividend Growth History for AMGN
Historical Annual Dividend Data & Growth

AMGN Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$4.0000 2016 26.6%
$3.1600 2015 29.5%
Historical Dividend Data

AMGN Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$1.1500 2016-12-20 2017-02-13 2017-02-15 2017-03-08 Yes Regular Quarter
$1.0000 2016-10-14 2016-11-14 2016-11-16 2016-12-08 Yes Regular Quarter
$1.0000 2016-07-22 2016-08-15 2016-08-17 2016-09-08 Yes Regular Quarter
$1.0000 2016-03-02 2016-05-13 2016-05-17 2016-06-08 Yes Regular Quarter
$1.0000 2015-12-15 2016-02-11 2016-02-16 2016-03-08 Yes Regular Quarter
$0.7900 2015-10-14 2015-11-12 2015-11-16 2015-12-07 Yes Regular Quarter
$0.7900 2015-07-28 2015-08-13 2015-08-17 2015-09-08 Yes Regular Quarter
$0.7900 2015-03-04 2015-05-12 2015-05-14 2015-06-05 Yes Regular Quarter
$0.7900 2014-12-17 2015-02-10 2015-02-12 2015-03-06 Yes Regular Quarter
$0.6100 2014-10-17 2014-11-10 2014-11-13 2014-12-05 Yes Regular Quarter
$0.6100 2014-07-25 2014-08-12 2014-08-14 2014-09-05 Yes Regular Quarter
$0.6100 2014-03-05 2014-05-13 2014-05-15 2014-06-06 Yes Regular Quarter
$0.6100 2013-12-13 2014-02-11 2014-02-13 2014-03-07 Yes Regular Quarter
$0.4700 2013-10-16 2013-11-12 2013-11-14 2013-12-06 Yes Regular Quarter
$0.4700 2013-07-26 2013-08-14 2013-08-16 2013-09-06 Yes Regular Quarter
$0.4700 2013-03-06 2013-05-14 2013-05-16 2013-06-07 Yes Regular Quarter
$0.4700 2012-12-13 2013-02-11 2013-02-13 2013-03-07 Yes Regular Quarter
$0.3600 2012-10-11 2012-11-13 2012-11-15 2012-12-07 Yes Regular Quarter
$0.3600 2012-07-19 2012-08-14 2012-08-16 2012-09-07 Yes Regular Quarter
$0.3600 2012-03-15 2012-05-14 2012-05-16 2012-06-07 Yes Regular Quarter
$0.3600 2011-12-15 2012-02-13 2012-02-15 2012-03-07 Yes Regular Quarter
$0.2800 2011-10-13 2011-11-15 2011-11-17 2011-12-08 Yes Regular Quarter
$0.2800 2011-07-28 2011-08-16 2011-08-18 2011-09-08 Yes Regular Quarter
2-for-1 1999-10-20 1999-11-22 1999-11-05 1999-11-19 NM Stock Split NM
2-for-1 1999-01-28 1999-03-01 1999-02-12 1999-02-26 NM Stock Split NM
$0.0002 1997-02-19 1997-03-24 1997-03-21 1997-03-21 Unknown Unknown unknown
2-for-1 1995-07-20 1995-08-16 1995-08-01 1995-08-15 NM Stock Split NM

Knowledge Centers

Company Profile

AMGN Company Profile

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology

Amgen (AMGN) - this company discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

Amgen News

  • After the bell on Tuesday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings reports and break down the important points for investors.

  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About...

  • Dividends are an effective income generation tool for both short- and long-term investors. To capitalize on dividends, investors must ensure that they purchase the stock before the ex-dividend date and hold the stock through this period. Payments...

  • After last week’s continued bout of volatility, investors are going to experience smooth sailing this week. (I can’t even type that with a straight face.) This week really promises to be another rollercoaster of news- and data-driven surges and...

  • At this point, investor’s should be used to the up and down swings of the market. The last trading week of the month proved to be another roller coaster ride for stocks as investors digested a ton of data, policy announcements and earnings...

  • There are 15 major stocks going ex-dividend next week. If you buy the stock one day prior to the ex-dividend date, your name goes on the company’s record books and you receive the dividend on the record date. A stock with the least correction off...

  • When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development....

  • There are 173 stocks going ex-dividend this week, starting Monday, November 14. For income investors looking to generate more income as part of a dividend capture strategy, a stock must be purchased one day before the ex-dividend date to capture...

  • Ex-dividend dates are important to dividend investors since a stock must be purchased prior to its ex-dividend date in order for the investor to receive its upcoming payout. For more information, check out Everything Investors Need to Know About...

  • “(Share buybacks) are a colossal waste of company money”.

    - says while dropping the mic and walking off the stage…

    If you’ve been part of our community for any amount of time (heck, even if you’re new)...